Pacira BioSciences, Inc. — Form SCHEDULE 13D/A
Filed October 13, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
▼ Likely negative
significance 72/100
What the filing says
On October 8–13, 2026, Pedro Escudero (directly and via DOMA Perpetual LO Equity Master Fund LP, The John Templeton Foundation, and affiliated LLCs) sold a combined 2,936,794 shares of Pacira at ~$36.29–$36.34 per share, generating approximately $106.7M in gross proceeds. The entities executed a joint filing agreement on October 13, 2026, confirming coordinated SEC reporting. No disclosure states the rationale, size of remaining stake, or whether this represents a full exit.
Why this rating
~$107M in aggregate sales (~14% of company market cap) by a single coordinated investor group signals confidence loss, despite no explicit disclosure of stake size or exit rationale. Material overhang and perception risk.
Tradability signal
SHORT
conviction 29/100 · expected -0.49% over 4 hrs
SHORT (drift): bad news keeps sliding after dissemination — our one persistent measured edge. Similar past filings (44 in this cell) moved +0.76% in the called direction over 4 hrs; shrunk for sample size that's a +0.49% edge. Price is up 0.0% since the filing hit EDGAR — market hasn't digested it yet. Exit plan: HARD stop 2.5% against entry — 1.4× this stock's measured hourly volatility, fixed, not trailing (trails test terribly on these names) — time exit 4 hrs. (Filing arrived outside market hours — evaluated at the next open with a live quote.)
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it negative)
at our read · unknown $36.32 | +10 min · unknown $36.33 ▲ 0.01% | +30 min · unknown $36.33 ▲ 0.01% | +1 hr · unknown $36.33 ▲ 0.03% | +4 hrs · unknown $36.38 ▲ 0.15% |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from October 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.